CD4+ CD56+ Cutaneous Neoplasms: A Distinct Hematological Entity?-Reference-Cited by-同舟云学术

CD4+ CD56+ Cutaneous Neoplasms: A Distinct Hematological Entity?

Published:1999-02 Issue:2 Volume:23 Page:137-146
ISSN:0147-5185
Container-title:The American Journal of Surgical Pathology
language:en
Short-container-title:The American Journal of Surgical Pathology

Author:

Petrella Tony,Dalac Sophie,Maynadié Marc,Mugneret Francine,Thomine Elisabeth,Courville Philippe,Joly Pascal,Lenormand Bernard,Arnould Laurent,Wechsler Janine,Bagot Martine,Rieux Claire,Bosq Jacques,Avril Marie-Françoise,Bernheim Alain,Molina Thierry,Devidas Alain,Delfau-Larue Marie-Hélène,Gaulard Philippe,Lambert Daniel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference64 articles.

1. NCAM polysialic acid can regulate both cell-cell and cell-substrate interactions.

2. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma

3. CD56-positive (nasal-type T/NK cell) lymphoma arising on the skin

4. Primary Cutaneous Natural Killer/ T-Cell Lymphoma

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumeur à cellules dendritiques plasmocytoïdes blastiques;Annales de Dermatologie et de Vénéréologie - FMC;2024-05

2. Cutaneous Lymphomas;Rook's Textbook of Dermatology;2024-03-19

3. Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas;Cells;2023-11-20

4. Blastic Plasmacytoid Dendritic Cell Neoplasm;Advances in Molecular Pathology;2023-11

5. Comparison and Development of Immunohistochemical Diagnostic Criteria for Blastic Plasmacytoid Dendritic Cell Neoplasm;Modern Pathology;2023-10